期刊文献+

高产AmpC酶阴沟肠杆菌感染的临床危险因素分析 被引量:22

Enterobacter cloacae Infections with High-level AmpC β-Lactamase: A Clinical Study
下载PDF
导出
摘要 目的 分析导致高产AmpC酶阴沟肠杆菌感染的临床危险因素。方法 收集阴沟肠杆菌所致的各种临床感染病例 ,头孢西丁三维试验测定各临床病例中分离得到的阴沟肠杆菌的AmpC酶产生情况 ,回顾性比较两组病例在年龄、基础疾病伴发率、细菌学检查前的住院时间及 β 内酰胺类抗生素使用时间、死亡率等方面的差异。结果 在收集到的全部 4 0例阴沟肠杆菌感染病例中 ,由高产AmpC酶阴沟肠杆菌所致者 12例 (30 % ) ,非高产 2 8例 (70 % ) ;高产AmpC酶阴沟肠杆菌感染患者在细菌学检查前使用 β 内酰胺类抗生素的时间为(9.83± 1.93)d ,而非高产AmpC酶组为 (3.10± 0 .78)d ,两者差异非常显著 (P =0 .0 0 0 2 ) ;两组患者在年龄、基础疾病伴发率及细菌学检查前的住院时间方面差异无显著性 (P >0 .0 5 )。结论 较长时间使用 β 内酰胺类抗生素是导致高产Am pC酶阴沟肠杆菌感染的临床主要危险因素。 OBJECTIVE To investigate the clinical factors of Enterobacter cloacae infections with high-level AmpC β-lactamase. METHODS The cases infected by E.cloacae were collected. The patients were divided into two groups: high-level AmpC β-lactamase (HAmpC) and non-high-level AmpC β-lactamase (NHAmpC) according to three-dimensional extracts tests. Compared the difference of age, rate of basic diseases, hospitalization time (HT) and β-lactam antibiotics using time(βAT) before E. cloacae isolated. RESULTS Among 40 cases, 12 (30%) were high-level AmpC β-lactamase E. cloacae infection, 28(70%) were non-high-level AmpC β-lactamase E. cloacae infection. There was a significant difference in βAT between two groups, HAmpC with a mean of 9.83 days and NHAmpC 3.10 days, P=0.0002. There was no difference among age, rate of basic diseases and HT between two groups. CONCLUSIONS β-Lactam antibiotics may contribute to high-level AmpC β-lactamase in E. cloacae infection.
出处 《中华医院感染学杂志》 CAS CSCD 2003年第6期511-513,共3页 Chinese Journal of Nosocomiology
关键词 阴沟肠杆菌 抗药性 微生物 Β-内酰胺酶类 Enterobacter cloacae Resistance Antibiotics β-lactamase
  • 引文网络
  • 相关文献

参考文献5

  • 1佘丹阳,刘又宁.AmpC酶和超广谱β-内酰胺酶在阴沟肠杆菌中的表达及对其耐药性的影响[J].中华医学杂志,2002,82(19):1355-1358. 被引量:86
  • 2Jones RN. Importment and emerging β-lactamase-mediated resistanee in hospital-based pathogens: the AmpC enzymes[J].Diagn Mierobiol Infect Dis, 1998, 31.-461-466.
  • 3Langaee TY, Gagnon L, Huletsky A. Inactivation of the AmpD gene in Pseudomonas aeruginosa leads to moderatebasal-level and hyperinducible AmpCβ-lactamase expression[J]. Antimicrob Agents Chemother, 2000, 44:583-589.
  • 4Korfmann G, Sanders CC, Moland ES. Altered phenotypes associated with AmpD mutation in E. cloacae[J]. Antimicrob Agents Chemother, 1991, 35:358-364.
  • 5Chan WC, Li RC, Ling JM, et al. Markedly different rates and resistance profiles exhibited by seven commonly used and newer β-lactams on the selection of resistant variants of Enterobacter cloacae[J]. J Antimicrob Chemother, 1999, 44:55-60.

二级参考文献9

  • 1Livermore DM, Williams JD. β-lactams: mode of action and mechanisms of bacterial resistance. In: Lorian V, eds. Antibiotics in laboratory medicine. 4th ed. Baltimore:Williams & Wilkins, 1996. 502-578.
  • 2Sanders CC. β-lactamase of gram negative bacteria: new challenges for new drugs. Clin Infect Dis, 1992,14:1089-1099.
  • 3Naumiuk L, Samet A, Dziemaszkiewicz E. Cefepime in vitro activity against derepressed extended-spectrum β-lactamase(ESBL)-producing and non-ESBL-producing Enterobacter cloacae by a disc diffusion method. J Antimicrob Chemother, 2001,48:321-322.
  • 4National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. 9th informational supplement(M100-S9). Wayne:NCCLS,1999.
  • 5Coudron PE,Moland ES, Thomson KS. Occurrence and detection of AmpC β-lactamases among Escherichia coli,Klebsiella pneumoniae,and Proteus mirabilis isolates at a veterans medical center. J Clin Microbiol, 2000, 38:1791-1796.
  • 6Tzelepi E, Giakkoupi P, Sofianou D, et al. Detection of extended-spectrum β-lactamases in clinical isolates of Enterobacter cloacae and Enterobacter aerogenes. J Clin Microbiol, 2000,38:542-546.
  • 7Chanal C, Sirot D, Romaszko JP, et al. Survey of extended-spectrum β-lactamases among Enterobacteriaceae. J Antimicrob Chemother, 1996, 38:127-132.
  • 8Coudron PE,Moland ES, Sanders CC. Occurrence and detection of extended-spectrum β-lactamases in members of the family Enterobacteriaceae at a veterans medical center: seek and you may find. J Clin Microbiol, 1997, 35:2593-2597.
  • 9王辉,吴伟元,陈民钧.肠杆菌科细菌中超广谱β-内酰胺酶(ESBL)的研究[J].中华微生物学和免疫学杂志,2001,21(6):676-679. 被引量:100

共引文献85

同被引文献164

引证文献22

二级引证文献300

;
使用帮助 返回顶部